Iopromide versus diatrizoate. A comparative study of adverse reactions.
One hundred patients were at random given an intravenous injection of equal amounts of either diatrizoate or iopromide. Subjective patient discomfort and objective parameters of adverse reactions were recorded. There were significantly fewer patients with adverse effects in the iopromide group, both as an overall estimate and especially for heat sensation, nausea and increase in heart rate. Iopromide is recommended for increased patient safety.